packageBlinatumomab

blinatumomab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Blinatumomab is a monoclonal antibody anticancer medicine used to treat a form of lymphoblastic leukaemia-lymphoma. It is authorised in the European Union and is also being studied for other uses.

Summary written by glm-5.3-flash from Wikidata Q410189 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:blinatumomab
ATC codes:L01FX07
DrugBank:DB09052
Wikidata:Q410189
molar mass:54100 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown